Clinical Trials Transformation Initiative (CTTI) has released a report of recommendations on best practice in clinical trials during the COVID-19 pandemic.

These recommendations have been created from a global survey on experiences and best practice in the context of the US FDA guidance on the conduct of clinical trials of medical products during the pandemic.

Responses were received from 327 members from 154 countries. CTTI determined that areas requiring the most modification pertained to sponsors, essential documents and investigators.